A comparative study between excess-dose users and regular-dose users of rhubarb contained in Kampo medicines

N. Mantani, T. Kogure, S. Sakai, M. Kainuma, Y. Kasahara, A. Niizawa, Y. Shimada, K. Terasawa

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

With prolonged use of rhubarb-containing Kampo medicines, some patients come to ask for high-dose rhubarb because of deteriorated reactivity to rhubarb. We divided patients into two groups in terms of rhubarb-dose, and compared clinical backgrounds between regular-dose group and excess-dose group. Patients who were treated with rhubarb-containing Kampo extracts (manufactured prescriptions) or Kampo formulae (decoctions) for more than 12 months were enrolled. These two groups were compared for age, sex, shape of stool, abdominal symptoms, existence of hemorrhoids, Kampo diagnosis of abdomen, past stimulant laxative use, duration of stimulant laxative use before the first administration of rhubarb, duration of rhubarb use in our hospital, and initial existence of stimulant pain caused by taking stimulant laxatives for the first time. No significant difference was shown between the two groups in terms of age, duration of stimulant laxative-use before the first prescription of rhubarb, shape of stool, abdominal symptoms, existence of hemorrhoids, or duration of rhubarb-use. However, most patients in the regular-dose group had initial stimulant pain of the abdomen upon taking stimulant laxatives for the first time, but most patients in the excess-dose group did not (p < 0.001). All patients except one in the regular dose group had the sign of "umbilical region tenderness on pressure", but half of the excess-dose group did not have it (p = 0.041). Based on these findings, the absence of "initial stimulant pain" and the absence of "umbilical region tenderness on pressure" may predict increasing or excess use of rhubarb, and long-term use of rhubarb should be discouraged more strongly in the patients without these signs.

Original languageEnglish
Pages (from-to)373-376
Number of pages4
JournalPhytomedicine
Volume9
Issue number5
DOIs
Publication statusPublished - Jan 1 2002
Externally publishedYes

Fingerprint

Kampo Medicine
Rheum
Laxatives
Umbilicus
Hemorrhoids
Pain
Abdomen
Prescriptions
Pressure

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Complementary and alternative medicine

Cite this

A comparative study between excess-dose users and regular-dose users of rhubarb contained in Kampo medicines. / Mantani, N.; Kogure, T.; Sakai, S.; Kainuma, M.; Kasahara, Y.; Niizawa, A.; Shimada, Y.; Terasawa, K.

In: Phytomedicine, Vol. 9, No. 5, 01.01.2002, p. 373-376.

Research output: Contribution to journalArticle

Mantani, N, Kogure, T, Sakai, S, Kainuma, M, Kasahara, Y, Niizawa, A, Shimada, Y & Terasawa, K 2002, 'A comparative study between excess-dose users and regular-dose users of rhubarb contained in Kampo medicines', Phytomedicine, vol. 9, no. 5, pp. 373-376. https://doi.org/10.1078/09447110260571580
Mantani, N. ; Kogure, T. ; Sakai, S. ; Kainuma, M. ; Kasahara, Y. ; Niizawa, A. ; Shimada, Y. ; Terasawa, K. / A comparative study between excess-dose users and regular-dose users of rhubarb contained in Kampo medicines. In: Phytomedicine. 2002 ; Vol. 9, No. 5. pp. 373-376.
@article{4ea072c728c54a1d81399c5ae09806d2,
title = "A comparative study between excess-dose users and regular-dose users of rhubarb contained in Kampo medicines",
abstract = "With prolonged use of rhubarb-containing Kampo medicines, some patients come to ask for high-dose rhubarb because of deteriorated reactivity to rhubarb. We divided patients into two groups in terms of rhubarb-dose, and compared clinical backgrounds between regular-dose group and excess-dose group. Patients who were treated with rhubarb-containing Kampo extracts (manufactured prescriptions) or Kampo formulae (decoctions) for more than 12 months were enrolled. These two groups were compared for age, sex, shape of stool, abdominal symptoms, existence of hemorrhoids, Kampo diagnosis of abdomen, past stimulant laxative use, duration of stimulant laxative use before the first administration of rhubarb, duration of rhubarb use in our hospital, and initial existence of stimulant pain caused by taking stimulant laxatives for the first time. No significant difference was shown between the two groups in terms of age, duration of stimulant laxative-use before the first prescription of rhubarb, shape of stool, abdominal symptoms, existence of hemorrhoids, or duration of rhubarb-use. However, most patients in the regular-dose group had initial stimulant pain of the abdomen upon taking stimulant laxatives for the first time, but most patients in the excess-dose group did not (p < 0.001). All patients except one in the regular dose group had the sign of {"}umbilical region tenderness on pressure{"}, but half of the excess-dose group did not have it (p = 0.041). Based on these findings, the absence of {"}initial stimulant pain{"} and the absence of {"}umbilical region tenderness on pressure{"} may predict increasing or excess use of rhubarb, and long-term use of rhubarb should be discouraged more strongly in the patients without these signs.",
author = "N. Mantani and T. Kogure and S. Sakai and M. Kainuma and Y. Kasahara and A. Niizawa and Y. Shimada and K. Terasawa",
year = "2002",
month = "1",
day = "1",
doi = "10.1078/09447110260571580",
language = "English",
volume = "9",
pages = "373--376",
journal = "Phytomedicine",
issn = "0944-7113",
publisher = "Urban und Fischer Verlag Jena",
number = "5",

}

TY - JOUR

T1 - A comparative study between excess-dose users and regular-dose users of rhubarb contained in Kampo medicines

AU - Mantani, N.

AU - Kogure, T.

AU - Sakai, S.

AU - Kainuma, M.

AU - Kasahara, Y.

AU - Niizawa, A.

AU - Shimada, Y.

AU - Terasawa, K.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - With prolonged use of rhubarb-containing Kampo medicines, some patients come to ask for high-dose rhubarb because of deteriorated reactivity to rhubarb. We divided patients into two groups in terms of rhubarb-dose, and compared clinical backgrounds between regular-dose group and excess-dose group. Patients who were treated with rhubarb-containing Kampo extracts (manufactured prescriptions) or Kampo formulae (decoctions) for more than 12 months were enrolled. These two groups were compared for age, sex, shape of stool, abdominal symptoms, existence of hemorrhoids, Kampo diagnosis of abdomen, past stimulant laxative use, duration of stimulant laxative use before the first administration of rhubarb, duration of rhubarb use in our hospital, and initial existence of stimulant pain caused by taking stimulant laxatives for the first time. No significant difference was shown between the two groups in terms of age, duration of stimulant laxative-use before the first prescription of rhubarb, shape of stool, abdominal symptoms, existence of hemorrhoids, or duration of rhubarb-use. However, most patients in the regular-dose group had initial stimulant pain of the abdomen upon taking stimulant laxatives for the first time, but most patients in the excess-dose group did not (p < 0.001). All patients except one in the regular dose group had the sign of "umbilical region tenderness on pressure", but half of the excess-dose group did not have it (p = 0.041). Based on these findings, the absence of "initial stimulant pain" and the absence of "umbilical region tenderness on pressure" may predict increasing or excess use of rhubarb, and long-term use of rhubarb should be discouraged more strongly in the patients without these signs.

AB - With prolonged use of rhubarb-containing Kampo medicines, some patients come to ask for high-dose rhubarb because of deteriorated reactivity to rhubarb. We divided patients into two groups in terms of rhubarb-dose, and compared clinical backgrounds between regular-dose group and excess-dose group. Patients who were treated with rhubarb-containing Kampo extracts (manufactured prescriptions) or Kampo formulae (decoctions) for more than 12 months were enrolled. These two groups were compared for age, sex, shape of stool, abdominal symptoms, existence of hemorrhoids, Kampo diagnosis of abdomen, past stimulant laxative use, duration of stimulant laxative use before the first administration of rhubarb, duration of rhubarb use in our hospital, and initial existence of stimulant pain caused by taking stimulant laxatives for the first time. No significant difference was shown between the two groups in terms of age, duration of stimulant laxative-use before the first prescription of rhubarb, shape of stool, abdominal symptoms, existence of hemorrhoids, or duration of rhubarb-use. However, most patients in the regular-dose group had initial stimulant pain of the abdomen upon taking stimulant laxatives for the first time, but most patients in the excess-dose group did not (p < 0.001). All patients except one in the regular dose group had the sign of "umbilical region tenderness on pressure", but half of the excess-dose group did not have it (p = 0.041). Based on these findings, the absence of "initial stimulant pain" and the absence of "umbilical region tenderness on pressure" may predict increasing or excess use of rhubarb, and long-term use of rhubarb should be discouraged more strongly in the patients without these signs.

UR - http://www.scopus.com/inward/record.url?scp=0036628712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036628712&partnerID=8YFLogxK

U2 - 10.1078/09447110260571580

DO - 10.1078/09447110260571580

M3 - Article

C2 - 12222654

AN - SCOPUS:0036628712

VL - 9

SP - 373

EP - 376

JO - Phytomedicine

JF - Phytomedicine

SN - 0944-7113

IS - 5

ER -